Şunu aradınız:: risk of extinction (Danca - Hollandaca)

patients deemed at risk of infection
at risk of infection

adjunctive treatment in patients at risk of methotrexate
adjunctive treatment in patients at risk of methotrexate

minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products.
minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products.

guidelines minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products
richtsnoeren minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products

guidelines minimising the risk of transmitting animal spongiform encephalopathy agents via veterinary medicinal products
richtsnoeren minimising the risk of transmitting animal spongiform encephalopathy agents via veterinary medicinal products

note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products
note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products

incorrect application of the new eu rules and discriminatory technical solutions and practices could fragment the internal market and increase the risk of inefficiencies and bad governance.
incorrect application of the new eu rules and discriminatory technical solutions and practices could fragment the internal market and increase the risk of inefficiencies and bad governance.

in such cases the ecb shall endeavour to avoid the double processing of payment orders , but the participants shall bear the risk of such double processing if it occurred .
in such cases the ecb shall endeavour to avoid the double processing of payment orders , but the participants shall bear the risk of such double processing if it occurred .

den videnskabelige veterinærkomité har den 26. april erklæret følgende: dens første konklusion lyder: the committee concludes therefore that semen does not present a risk of transmission of bse.
welnu, het wetenschappelijk veterinair comité heeft op 26 april verklaard:" het comité concludeert derhalve dat sperma geen risico van overdracht van bse inhoudt".

titel på dokumentet note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
titel document note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines

titel på dokumentet revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/ 2003 plasma master file:
titel document revision of note for guidance on minimising the risks of tse transmission via medicinal products cpmp recommendations on vcjd and plasma derived medicinal products – cpmp recommendations on transmissible agents and urinary derived medicinal products note for guidance on the use of bovine serum used in the manufacture of human biological medicinal products note for guidance on the production and quality control of animal immunoglobins and immunosera for human use cell culture inactivated influenza vaccines – annex to note for guidance on harmonisation of requirements for influenza vaccines eu recommendations for the influenza vaccine composition for the season 2002/2003 plasma master file: